Stock Ticker

  • Loading stock data...

Eli Lilly And Co (NYSE:LLY) Commences First Human Trial Involving Its Antibody-based COVID-19 Treatment

Eli Lilly And Co (NYSE:LLY) revealed on Monday that it started testing human subjects with its developmental treatment for COVID-19, which is based on antibodies. The biopharma is currently working on phase 1 of the clinical trial, through which it aims to test the safety and efficacy of the drug. Eli Lilly plans to publish […]

Sign Up To Get Our Latest Stocks Alerts